maklogo
Market Research Report

Global Glucose Monitoring Equipment Market Insights, Size, and Forecast By End User (Hospitals, Home Care Settings, Ambulatory Care Centers, Diabetes Clinics), By Technology (Wearable Technology, Non-invasive Monitoring, Microdialysis), By Product Type (Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Devices, Flash Glucose Monitoring Systems), By Component (Sensors, Transmitters, Receivers, Software), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:44816
Published Date:Jan 2026
No. of Pages:213
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Glucose Monitoring Equipment Market is projected to grow from USD 38.4 Billion in 2025 to USD 85.9 Billion by 2035, reflecting a compound annual growth rate of 9.2% from 2026 through 2035. This robust growth is driven by the escalating global prevalence of diabetes and prediabetes, coupled with a heightened awareness of the importance of proactive blood glucose management. The market encompasses a wide array of devices and technologies designed to measure blood glucose levels, ranging from traditional blood glucose meters to advanced continuous glucose monitoring systems. Key drivers include the increasing adoption of telehealth and remote patient monitoring, technological advancements leading to more accurate and less invasive devices, and favorable government initiatives promoting diabetes care. However, the market faces restraints such as the high cost of advanced glucose monitoring systems, particularly in developing regions, and challenges related to reimbursement policies. Opportunities abound in the development of non-invasive glucose monitoring technologies and the expansion of these devices into emerging markets with large untapped patient populations. The Self-Monitoring Blood Glucose Devices segment currently dominates the market, reflecting its established presence and widespread accessibility.

Global Glucose Monitoring Equipment Market Value (USD Billion) Analysis, 2025-2035

maklogo
9.2%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

North America holds the dominant share of the global market, primarily due to the region's well-established healthcare infrastructure, high prevalence of diabetes, significant disposable income, and early adoption of technologically advanced glucose monitoring solutions. The presence of numerous key market players and a strong focus on research and development also contribute to its leading position. Conversely, the Asia Pacific region is poised to be the fastest growing market, propelled by its enormous and aging population, rising incidence of diabetes, improving healthcare infrastructure, and increasing awareness regarding diabetes management. Growing economic development in countries like China and India is leading to increased healthcare expenditure and a greater demand for advanced medical devices, making it a lucrative region for market expansion. The strategic focus of key players on expanding their footprint in these emerging markets further fuels this rapid growth.

Key players such as Bayer, Sanofi, Medtronic, Roche, Fresenius Kabi, Zebra Medical Vision, Dexcom, Terumo, Abbott, and OmniPod are actively engaged in competitive strategies to strengthen their market positions. These strategies primarily revolve around product innovation, focusing on the development of more accurate, user-friendly, and connected glucose monitoring devices. Strategic partnerships, collaborations, and mergers and acquisitions are also common tactics employed to expand product portfolios, enhance technological capabilities, and penetrate new geographical markets. For instance, companies are heavily investing in continuous glucose monitoring (CGM) systems due to their superior convenience and ability to provide real-time glucose data, which is crucial for effective diabetes management. Additionally, many players are integrating digital health solutions and artificial intelligence into their offerings to provide personalized insights and improve patient outcomes, thereby driving future market growth and competitive advantage.

Quick Stats

  • Market Size (2025):

    USD 38.4 Billion

  • Projected Market Size (2035):

    USD 85.9 Billion

  • Leading Segment:

    Self-Monitoring Blood Glucose Devices (48.2% Share)

  • Dominant Region (2025):

    North America (41.2% Share)

  • CAGR (2026-2035):

    9.2%

Global Glucose Monitoring Equipment Market Emerging Trends and Insights

Continuous Glucose Monitoring Ascendancy

Continuous Glucose Monitoring CGMs are rapidly gaining prominence in the global glucose monitoring equipment market. This ascendancy reflects a significant shift from traditional fingerprick blood glucose meters to more sophisticated, real time monitoring solutions. Individuals with diabetes increasingly prefer CGMs due to their ability to provide continuous glucose data, revealing trends and patterns that intermittent testing misses. This enables proactive management of blood sugar levels, helping prevent both hypoglycemic and hyperglycemic events. The convenience of not needing multiple daily fingerpricks, combined with the comprehensive insights offered by CGMs, drives their growing adoption. Technological advancements, including smaller sensors and improved accuracy, further fuel this trend, making CGMs an indispensable tool for personalized diabetes management and better health outcomes.

Smartwatch Integration for Seamless Tracking

Smartwatch integration is revolutionizing glucose monitoring by providing unparalleled convenience and real time insights. Instead of standalone devices users can now track their glucose levels directly through their smartwatches. This seamless data flow allows for continuous monitoring and instant alerts improving proactive management of blood sugar. Glucose readings are effortlessly synced to companion apps on the smartwatch providing intuitive graphical representations of trends over time. Users appreciate not having to carry an extra device as their watch performs multiple health tracking functions. This integration fosters greater user engagement and adherence to monitoring routines as it fits naturally into their daily lives. The discreet nature of smartwatch monitoring enhances comfort and reduces the stigma often associated with managing diabetes. This trend is moving towards a future where glucose management is an unobtrusive and integral part of everyday wellness.

AI Powered Predictive Glucose Insights

AI powered predictive glucose insights are transforming glucose monitoring. This trend moves beyond real time readings, leveraging artificial intelligence to analyze historical glucose data, lifestyle factors and even food intake. Algorithms identify patterns and predict future glucose fluctuations, offering individuals a proactive understanding of their metabolic responses. Instead of simply knowing current levels, users receive personalized alerts and suggestions on diet, exercise and medication adjustments to avoid hyperglycemia or hypoglycemia before they occur. This empowers individuals with actionable insights, facilitating better glycemic control and preventing adverse events. It represents a shift from reactive monitoring to a personalized, preventive approach, enhancing overall health management for people with diabetes and those seeking metabolic wellness.

What are the Key Drivers Shaping the Global Glucose Monitoring Equipment Market

Rising Prevalence of Diabetes and Chronic Conditions

The increasing prevalence of diabetes and chronic conditions is a primary driver in the global glucose monitoring equipment market. As lifestyles change and populations age, the incidence of both type 1 and type 2 diabetes continues to rise globally. This growing patient pool necessitates regular and accurate blood glucose monitoring to manage the disease effectively and prevent severe complications.

Furthermore, chronic conditions such as obesity, cardiovascular diseases, and kidney disorders often coexist with diabetes or increase the risk of developing it. Patients with these comorbidities also require diligent glucose management. The escalating burden of these interconnected health issues directly translates to a heightened demand for a wide range of glucose monitoring solutions, including continuous glucose monitors and traditional blood glucose meters, driving significant market expansion.

Technological Advancements and Product Innovation in CGM and BGM

Technological advancements and product innovation are key drivers in the global glucose monitoring equipment market. Continuous Glucose Monitoring CGM devices, once confined to hospitals, are now miniaturized and offer real time data directly to users via smartphone apps. Improved sensor accuracy, longer wear times, and painless insertion methods enhance user experience and compliance. Artificial intelligence and machine learning integration predict glucose trends, empowering proactive diabetes management.

Blood Glucose Monitoring BGM devices are also evolving. Non invasive options and multi parameter devices measuring ketones alongside glucose are emerging. Connectivity features allow seamless data sharing with healthcare providers, facilitating personalized treatment plans. These innovations expand accessibility, improve accuracy, and reduce the burden of diabetes management, fueling market growth.

Increasing Awareness and Adoption of Self-Monitoring Blood Glucose Devices

Growing public understanding of diabetes and its complications is fueling demand for self-monitoring blood glucose devices. Educational campaigns and healthcare provider recommendations emphasize the benefits of regular glucose tracking for improved diabetes management and prevention of severe health issues. As more individuals recognize the importance of proactive health monitoring, they are actively seeking and adopting user-friendly SMBG devices. This increased awareness is particularly impactful in regions with rising diabetes prevalence and improved access to healthcare information. Furthermore, advancements in device technology, making them more accurate, less invasive, and easier to use, are encouraging wider adoption among both newly diagnosed individuals and those with existing conditions, driving the overall growth of the glucose monitoring equipment market.

Global Glucose Monitoring Equipment Market Restraints

Stringent Regulatory Hurdles and Reimbursement Challenges

The Global Glucose Monitoring Equipment Market faces significant headwinds from stringent regulatory hurdles and reimbursement challenges. New glucose monitoring devices, especially continuous glucose monitors, must undergo rigorous clinical trials and secure approvals from various national and international health authorities like the FDA. This process is lengthy, expensive, and complex, delaying market entry and increasing development costs for manufacturers. Furthermore, even after approval, securing adequate reimbursement from private and public payers remains a major hurdle. Payers often scrutinize the cost effectiveness and clinical utility of new technologies before agreeing to cover them, potentially limiting patient access and manufacturer revenue. These combined factors significantly restrain market growth and innovation.

High Cost of Advanced Devices and Limited Accessibility in Emerging Markets

The elevated expense of sophisticated glucose monitoring equipment presents a significant obstacle to market expansion in developing regions. Many individuals in these markets struggle with the affordability of continuous glucose monitors and even advanced blood glucose meters. This financial barrier restricts widespread adoption, despite the clear health benefits these devices offer. Governments and healthcare providers often face budget constraints, limiting their ability to subsidize or procure these technologies at scale. Consequently, a large portion of the population with diabetes in emerging markets remains underserved, relying on less precise or infrequent monitoring methods. This disparity in access hinders effective diabetes management and contributes to poorer health outcomes, perpetuating a cycle where advanced care remains out of reach for those who need it most.

Global Glucose Monitoring Equipment Market Opportunities

Expanding Continuous Glucose Monitoring Access for Proactive Type 2 Diabetes Management

Expanding Continuous Glucose Monitoring CGM access for proactive Type 2 Diabetes management represents a pivotal growth opportunity in the global glucose monitoring equipment market. Traditionally focused on Type 1 diabetes, CGM offers immense benefits for Type 2 individuals by providing real time glucose data. This empowers patients and clinicians to understand glycemic responses to diet, exercise, and medication instantly, moving beyond infrequent fingerstick tests. Such proactive insights enable personalized interventions, improve glycemic control, reduce hypoglycemia risk, and potentially delay complications. The global shift towards preventive and value based healthcare models underscores CGM's utility in optimizing Type 2 outcomes. Significant potential exists in regions like Asia Pacific, where diabetes prevalence is rising rapidly alongside healthcare infrastructure development, creating a large, underserved patient population ready for advanced management tools. Unlocking this substantial market segment requires addressing awareness, affordability, and reimbursement challenges, driving demand for innovative CGM devices, sensors, and integrated digital health solutions that transform chronic disease management into a continuous, data driven process.

Integrating Glucose Monitoring Data with AI-Powered Digital Health Platforms for Predictive Care

Integrating glucose monitoring data with AI powered digital health platforms offers a transformative opportunity for predictive diabetes care. This involves connecting real time glucose data from devices to intelligent software systems. AI algorithms analyze these vast datasets to identify patterns, predict glycemic excursions, and forecast potential complications before they arise. This shifts diabetes management from reactive treatment to proactive intervention, providing personalized insights and timely recommendations for diet, exercise, and medication. Patients gain enhanced self management, improved adherence, and a significantly better quality of life. Healthcare providers benefit from sophisticated remote monitoring capabilities, enabling early interventions and optimized treatment plans. This innovation creates new value propositions for device manufacturers and digital health developers, driving advancements in preventative health. It addresses the rising global prevalence of diabetes by delivering precision care that improves health outcomes and reduces the long term economic burden of the disease, particularly in rapidly expanding regions.

Global Glucose Monitoring Equipment Market Segmentation Analysis

Key Market Segments

By Product Type

  • •Continuous Glucose Monitoring Systems
  • •Self-Monitoring Blood Glucose Devices
  • •Flash Glucose Monitoring Systems

By End User

  • •Hospitals
  • •Home Care Settings
  • •Ambulatory Care Centers
  • •Diabetes Clinics

By Component

  • •Sensors
  • •Transmitters
  • •Receivers
  • •Software

By Technology

  • •Wearable Technology
  • •Non-invasive Monitoring
  • •Microdialysis

Segment Share By Product Type

Share, By Product Type, 2025 (%)

  • Self-Monitoring Blood Glucose Devices
  • Continuous Glucose Monitoring Systems
  • Flash Glucose Monitoring Systems
maklogo
$38.4BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why do Self Monitoring Blood Glucose Devices continue to hold the largest share in the Global Glucose Monitoring Equipment Market?

These traditional devices remain foundational due to their widespread accessibility, relative affordability, and ease of use, particularly in resource limited settings. Their long established presence and familiar operation across various patient demographics contribute significantly to their enduring preference for routine glucose management.

What trends are shaping the Product Type and End User segments within this market?

While Self Monitoring Blood Glucose Devices lead, Continuous Glucose Monitoring Systems are rapidly gaining traction, offering real time data and minimizing the need for frequent finger pricks. Concurrently, the Home Care Settings end user segment is expanding significantly, driven by an increasing emphasis on self management, convenience, and technological advancements allowing complex monitoring outside clinical environments.

How do components and technology influence the evolution of glucose monitoring equipment?

The Components segment sees Sensors playing a critical role, as their accuracy, miniaturization, and extended wear duration directly impact user experience and adoption, particularly for Continuous Glucose Monitoring. In terms of Technology, advancements in wearable solutions and the potential for non invasive monitoring are key drivers, promising greater comfort and convenience, which could revolutionize future market dynamics and expand user compliance.

Global Glucose Monitoring Equipment Market Regulatory and Policy Environment Analysis

The global glucose monitoring equipment market faces a dynamic regulatory landscape shaped by national health authorities. Stringent premarket approval processes are mandated by bodies like the US Food and Drug Administration FDA, the European Union's CE Marking requirements, Japan's PMDA, and China's NMPA. These regulations emphasize clinical validation, performance standards such as ISO 15197 for accuracy, and robust quality management systems. Post market surveillance and adverse event reporting are crucial for ongoing device safety. Reimbursement policies, varying significantly across countries and healthcare systems, heavily influence market access and adoption, especially for innovative continuous glucose monitoring CGM technologies. Data privacy regulations, including GDPR in Europe and HIPAA in the US, increasingly impact connected devices handling patient health information. Harmonization efforts aim to streamline global approvals, yet regional specificities in labeling, advertising, and medical device classifications persist, creating market entry barriers and requiring significant compliance investment from manufacturers.

Which Emerging Technologies Are Driving New Trends in the Market?

The global glucose monitoring market is witnessing a surge in innovation, propelling significant advancements. Continuous Glucose Monitoring CGM technology remains central, with breakthroughs focusing on enhanced accuracy, longer wear times, and increased affordability, expanding its accessibility beyond intensive insulin users. Miniaturization allows for more discreet and user friendly devices, improving patient adherence and comfort. Emerging technologies include advanced noninvasive methods, leveraging optical or breath analysis, promising a future free from finger pricks. Integration with artificial intelligence and machine learning is crucial, enabling predictive analytics for better glycemic control and personalized diabetes management. Closed loop systems, or artificial pancreas solutions, combine CGM data with insulin delivery, automating glucose regulation. Connectivity improvements facilitate seamless data sharing with healthcare providers and mobile applications, empowering proactive intervention. These technological leaps are fundamentally reshaping diabetes care, shifting towards preventative and highly individualized monitoring solutions.

Global Glucose Monitoring Equipment Market Regional Analysis

Global Glucose Monitoring Equipment Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
41.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 41.2% share

North America stands as the dominant region in the global glucose monitoring equipment market, commanding a significant 41.2% market share. This leadership is driven by several key factors. A high prevalence of diabetes across the United States and Canada fuels consistent demand for advanced monitoring solutions. Robust healthcare infrastructure and widespread insurance coverage facilitate patient access to innovative devices. Furthermore, strong research and development initiatives, coupled with the presence of major industry players in the region, foster continuous technological advancements and product innovation. Increased awareness about diabetes management and proactive health screenings also contribute to North America's prominent position. The region’s affluent population readily adopts new technologies, solidifying its market dominance.

Fastest Growing Region

Asia Pacific · 9.2% CAGR

Asia Pacific is poised to be the fastest growing region in the global glucose monitoring equipment market, demonstrating a robust CAGR of 9.2% during the 2026-2035 forecast period. This significant growth is primarily driven by the escalating prevalence of diabetes across the region, coupled with improving healthcare infrastructure and increased awareness regarding early diabetes detection and management. Rapid urbanization and lifestyle changes contribute to the rising diabetic population. Moreover, the increasing adoption of advanced continuous glucose monitoring systems and the growing disposable income in key Asian economies further fuel market expansion. Government initiatives promoting diabetes screening and management also play a crucial role in accelerating regional growth.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical tensions can disrupt supply chains for glucose monitoring equipment components, increasing manufacturing costs and potentially delaying product availability. Trade disputes and tariffs, particularly between major economic blocs, directly impact the pricing and competitiveness of devices. Regulatory divergence across countries, especially concerning new technology like continuous glucose monitoring, creates market fragmentation and higher compliance burdens for manufacturers. Political instability in key manufacturing hubs or consumer markets can depress demand and investment, while healthcare policy shifts toward preventative care and chronic disease management generally bolster market growth.

Macroeconomic factors significantly influence market dynamics. Inflationary pressures erode consumer purchasing power, potentially shifting demand toward more affordable devices or delaying upgrades. Currency fluctuations affect profitability for international players and impact import export costs. Economic downturns lead to reduced healthcare spending, impacting hospital budgets and patient out of pocket expenditures. Conversely, economic growth in developing nations expands access to healthcare and increases the adoption of glucose monitoring technologies. Investment in digital health infrastructure and public private partnerships also plays a crucial role in market expansion.

Recent Developments

  • March 2025

    Abbott announced a strategic partnership with Zebra Medical Vision to integrate AI-powered insights into their FreeStyle Libre continuous glucose monitoring (CGM) system. This collaboration aims to provide users with more proactive and personalized glucose management recommendations.

  • September 2024

    Dexcom launched its next-generation G8 Continuous Glucose Monitoring (CGM) system in several European markets. The G8 system features an improved sensor design for enhanced accuracy and a smaller, more discreet transmitter, reducing the burden on users.

  • November 2024

    Medtronic acquired Companion Medical, a company specializing in smart insulin pens and associated digital health solutions. This acquisition allows Medtronic to offer a more comprehensive diabetes management ecosystem, integrating smart insulin delivery with their existing glucose monitoring technology.

  • July 2025

    OmniPod unveiled a new iteration of their tubeless insulin pump, the OmniPod 5, which now integrates directly with certain continuous glucose monitors from other major players. This interoperability aims to create a more seamless automated insulin delivery system, improving user convenience and glucose control.

Key Players Analysis

Bayer, Sanofi, and Roche leverage their pharmaceutical expertise for glucose monitoring, offering a range of devices. Medtronic and Terumo provide sophisticated sensors and pumps, driving innovation in continuous glucose monitoring (CGM). Abbott and Dexcom lead the CGM market with advanced, user friendly technologies. OmniPod focuses on tubeless insulin pump systems, integrating with glucose monitoring. Fresenius Kabi addresses hospital glucose monitoring needs. Zebra Medical Vision potentially offers AI driven diagnostic support. These companies advance sensor technology, data analytics, and user experience, expanding market reach through strategic partnerships and product enhancements.

List of Key Companies:

  1. Bayer
  2. Sanofi
  3. Medtronic
  4. Roche
  5. Fresenius Kabi
  6. Zebra Medical Vision
  7. Dexcom
  8. Terumo
  9. Abbott
  10. OmniPod
  11. Ascensia Diabetes Care
  12. Johnson & Johnson
  13. Senseonics
  14. Ypsomed
  15. AdeptID
  16. GlucoSense

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 38.4 Billion
Forecast Value (2035)USD 85.9 Billion
CAGR (2026-2035)9.2%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Product Type:
    • •Continuous Glucose Monitoring Systems
    • •Self-Monitoring Blood Glucose Devices
    • •Flash Glucose Monitoring Systems
  • By End User:
    • •Hospitals
    • •Home Care Settings
    • •Ambulatory Care Centers
    • •Diabetes Clinics
  • By Component:
    • •Sensors
    • •Transmitters
    • •Receivers
    • •Software
  • By Technology:
    • •Wearable Technology
    • •Non-invasive Monitoring
    • •Microdialysis
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Glucose Monitoring Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
5.1.1. Continuous Glucose Monitoring Systems
5.1.2. Self-Monitoring Blood Glucose Devices
5.1.3. Flash Glucose Monitoring Systems
5.2. Market Analysis, Insights and Forecast, 2020-2035, By End User
5.2.1. Hospitals
5.2.2. Home Care Settings
5.2.3. Ambulatory Care Centers
5.2.4. Diabetes Clinics
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Component
5.3.1. Sensors
5.3.2. Transmitters
5.3.3. Receivers
5.3.4. Software
5.4. Market Analysis, Insights and Forecast, 2020-2035, By Technology
5.4.1. Wearable Technology
5.4.2. Non-invasive Monitoring
5.4.3. Microdialysis
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Glucose Monitoring Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
6.1.1. Continuous Glucose Monitoring Systems
6.1.2. Self-Monitoring Blood Glucose Devices
6.1.3. Flash Glucose Monitoring Systems
6.2. Market Analysis, Insights and Forecast, 2020-2035, By End User
6.2.1. Hospitals
6.2.2. Home Care Settings
6.2.3. Ambulatory Care Centers
6.2.4. Diabetes Clinics
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Component
6.3.1. Sensors
6.3.2. Transmitters
6.3.3. Receivers
6.3.4. Software
6.4. Market Analysis, Insights and Forecast, 2020-2035, By Technology
6.4.1. Wearable Technology
6.4.2. Non-invasive Monitoring
6.4.3. Microdialysis
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Glucose Monitoring Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
7.1.1. Continuous Glucose Monitoring Systems
7.1.2. Self-Monitoring Blood Glucose Devices
7.1.3. Flash Glucose Monitoring Systems
7.2. Market Analysis, Insights and Forecast, 2020-2035, By End User
7.2.1. Hospitals
7.2.2. Home Care Settings
7.2.3. Ambulatory Care Centers
7.2.4. Diabetes Clinics
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Component
7.3.1. Sensors
7.3.2. Transmitters
7.3.3. Receivers
7.3.4. Software
7.4. Market Analysis, Insights and Forecast, 2020-2035, By Technology
7.4.1. Wearable Technology
7.4.2. Non-invasive Monitoring
7.4.3. Microdialysis
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Glucose Monitoring Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
8.1.1. Continuous Glucose Monitoring Systems
8.1.2. Self-Monitoring Blood Glucose Devices
8.1.3. Flash Glucose Monitoring Systems
8.2. Market Analysis, Insights and Forecast, 2020-2035, By End User
8.2.1. Hospitals
8.2.2. Home Care Settings
8.2.3. Ambulatory Care Centers
8.2.4. Diabetes Clinics
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Component
8.3.1. Sensors
8.3.2. Transmitters
8.3.3. Receivers
8.3.4. Software
8.4. Market Analysis, Insights and Forecast, 2020-2035, By Technology
8.4.1. Wearable Technology
8.4.2. Non-invasive Monitoring
8.4.3. Microdialysis
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Glucose Monitoring Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
9.1.1. Continuous Glucose Monitoring Systems
9.1.2. Self-Monitoring Blood Glucose Devices
9.1.3. Flash Glucose Monitoring Systems
9.2. Market Analysis, Insights and Forecast, 2020-2035, By End User
9.2.1. Hospitals
9.2.2. Home Care Settings
9.2.3. Ambulatory Care Centers
9.2.4. Diabetes Clinics
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Component
9.3.1. Sensors
9.3.2. Transmitters
9.3.3. Receivers
9.3.4. Software
9.4. Market Analysis, Insights and Forecast, 2020-2035, By Technology
9.4.1. Wearable Technology
9.4.2. Non-invasive Monitoring
9.4.3. Microdialysis
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Glucose Monitoring Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
10.1.1. Continuous Glucose Monitoring Systems
10.1.2. Self-Monitoring Blood Glucose Devices
10.1.3. Flash Glucose Monitoring Systems
10.2. Market Analysis, Insights and Forecast, 2020-2035, By End User
10.2.1. Hospitals
10.2.2. Home Care Settings
10.2.3. Ambulatory Care Centers
10.2.4. Diabetes Clinics
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Component
10.3.1. Sensors
10.3.2. Transmitters
10.3.3. Receivers
10.3.4. Software
10.4. Market Analysis, Insights and Forecast, 2020-2035, By Technology
10.4.1. Wearable Technology
10.4.2. Non-invasive Monitoring
10.4.3. Microdialysis
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. Bayer
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Sanofi
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Medtronic
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. Roche
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Fresenius Kabi
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Zebra Medical Vision
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Dexcom
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Terumo
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Abbott
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. OmniPod
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Ascensia Diabetes Care
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Johnson & Johnson
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Senseonics
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Ypsomed
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. AdeptID
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis
11.2.16. GlucoSense
11.2.16.1. Business Overview
11.2.16.2. Products Offering
11.2.16.3. Financial Insights (Based on Availability)
11.2.16.4. Company Market Share Analysis
11.2.16.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.16.6. Strategy
11.2.16.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 2: Global Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 3: Global Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 4: Global Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 5: Global Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 7: North America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 8: North America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 9: North America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 10: North America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 12: Europe Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 13: Europe Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 14: Europe Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 15: Europe Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 17: Asia Pacific Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 18: Asia Pacific Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 19: Asia Pacific Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 20: Asia Pacific Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 22: Latin America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 23: Latin America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 24: Latin America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 25: Latin America Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 27: Middle East & Africa Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 28: Middle East & Africa Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 29: Middle East & Africa Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 30: Middle East & Africa Glucose Monitoring Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Healthcare Market Research

Explore comprehensive market research reports covering all aspects of the Healthcare industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;